Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 4/20 | 1.00 |
| ▸ | HTR2C | P28335 | 2/20 | 1.00 |
| ▸ | HTR2B | P41595 | 2/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.61 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.58 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.58 |
| ▸ | TUBB | P07437 | 2/20 | 0.58 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.58 |
| ▸ | TUBA1B | P68363 | 2/20 | 0.58 |
| ▸ | TUBA4A | P68366 | 2/20 | 0.58 |
| ▸ | TUBB4B | P68371 | 2/20 | 0.58 |
| ▸ | TUBB3 | Q13509 | 2/20 | 0.58 |
| ▸ | TUBB2A | Q13885 | 2/20 | 0.58 |
| ▸ | TUBB8 | Q3ZCM7 | 2/20 | 0.58 |
| ▸ | TUBA3E | Q6PEY2 | 2/20 | 0.58 |
| ▸ | TUBA1A | Q71U36 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mescaline SCHEMBL25170531 | 1.00 | HTR2A (1.00) | HTR2AHTR2CHTR2BCYP19A1KDM4E | |
| Mescaline SCHEMBL25272711 | 0.98 | HTR2A (0.96) | HTR2AHTR2CHTR2BCYP19A1KDM4E | |
| Mescaline SCHEMBL3219304 | 0.98 | HTR2A (0.96) | HTR2AHTR2CHTR2BCYP19A1KDM4E | |
| Mescaline SCHEMBL6056084 | 0.92 | HTR2A (0.85) | HTR2AHTR2CHTR2BCYP19A1KDM4E | |
| SCHEMBL20970881 | 0.89 | HTR2A (0.81) | HTR2AHTR2CHTR2BCYP19A1KDM4E | |
| SCHEMBL30261185 | 0.89 | HTR2A (0.81) | HTR2AHTR2CHTR2BCYP19A1KDM4E | |
| Mescaline SCHEMBL7637450 | 0.89 | HTR2A (0.79) | HTR2AHTR2CHTR2BCYP19A1KDM4E | |
| Mescaline SCHEMBL31079671 | 0.88 | HTR2A (0.79) | HTR2AHTR2CHTR2BCYP19A1KDM4E | |
| SCHEMBL31347535 | 0.88 | HTR2A (0.79) | HTR2AHTR2CHTR2BCYP19A1KDM4E | |
| SCHEMBL11291141 | 0.88 | HTR2A (0.79) | HTR2AHTR2CHTR2BCYP19A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6832 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132413-A1 | AROGENATE DEHYDROGENASE POLYNUCLEOTIDES, POLYPEPTIDES AND METHODS OF USING THE SAME | WISCONSIN ALUMNI RES FOUNDATION (US) | 2026-05-14 | — | — | US | claimed |
| EP-4731211-A1 | ALLYL- AND PROPARGYLAMINE-TYPE PHENETHYLAMINES AND TRYPTAMINES FOR TREATING MEDICAL DISORDERS | Definium Therapeutics US, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4728531-A1 | BIOADAPTIVE THERAPEUTIC ENVIRONMENTS | Therapod LLC (US) | 2026-04-22 | — | — | EP | claimed |
| US-12594388-B2 | Device to deliver a predetermined amount of a substance to a natural orifice of the body | APTARGROUP, INC. (US) | 2026-04-07 | — | — | US | claimed |
| US-20260090957-A1 | Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness | DRESDNER JR KARL P (US) | 2026-04-02 | — | — | US | claimed |
| US-20260083759-A1 | Combinations Comprising Psychedelics for the Treatment of Schizophrenia and Other Neuropsychiatric and Neurologic Disorders | HADASIT MED RES SERVICE (IL) | 2026-03-26 | — | — | US | claimed |
| US-20260080800-A1 | COMBINATION THERAPY WITH DIGITAL THERAPEUTICS FOR IMPROVED IMMUNE FUNCTION | REMEPY HEALTH LTD (IL) | 2026-03-19 | — | — | US | claimed |
| US-20260053878-A1 | PROCESS FOR EXTRACTION OF ACTIVE COMPOUNDS FROM PLANT BIOMASS | NEURAL THERAPEUTICS INC (CA) | 2026-02-26 | — | — | US | claimed |
| EP-4358962-B1 | TREATMENT FOR AUTOIMMUNE DISEASES COMPRISING NALTREXONE OR A METABOLITE OR ANALOG THEREOF, A CANNABINOID AND A 5-HT RECEPTOR AGONIST | LDN PHARMA LTD (GB) | 2026-02-04 | — | — | EP | claimed |
| US-12514883-B2 | Compositions and methods for modulating lipid and steroid metabolism | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-01-06 | — | — | US | claimed |
| WO-2002022801-A2 | MAMMALIAN RECEPTOR GENES AND USES | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2002-03-21 | — | — | WO | claimed |
| WO-2002005851-A2 | ENHANCEMENT OF THE ACTION OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM AGENTS | PITMY INTERNATIONAL N.V. (AN) | 2002-01-24 | — | — | WO | claimed |
| US-6150387-A | Heterocyclic carboxamide compounds effective in the treatment of drug abuse | RHONE-POULENC RORER S.A. (FR) | 2000-11-21 | — | — | US | claimed |
| US-6126924-A | Light responsive self-tanning products and methods for use | SCALES-MEDEIROS VIRGINIA A (US) | 2000-10-03 | — | — | US | claimed |
| JP-2000504681-A | — | — | 2000-04-18 | — | — | JP | claimed |
| EP-0879054-A1 | APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF MEDICAMENTS INTENDED TO THE TREATMENT OF DRUG ABUSE | Aventis Pharma S.A. (FR) | 1998-11-25 | — | — | EP | claimed |
| WO-1997029121-A1 | APPLICATION OF UREIDOACETAMIDES TO THE PREPARATION OF MEDICAMENTS INTENDED TO THE TREATMENT OF THE ABUSE OF DRUGS OR SUBSTANCES GIVING RISE TO PHARMACOMANIA OR TO AN EXCESSIVE USE | RHONE-POULENC RORER S.A. (FR) | 1997-08-14 | — | — | WO | claimed |
| WO-1997028800-A1 | USE OF THIAZOLIDINE DERIVATIVES TO PREPARE DRUGS FOR TREATING DRUGS ABUSE | RHONE-POULENC RORER S.A. (FR) | 1997-08-14 | — | — | WO | claimed |
| WO-1997028798-A1 | APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF MEDICAMENTS INTENDED TO THE TREATMENT OF DRUG ABUSE | RHONE-POULENC RORER S.A. (FR) | 1997-08-14 | — | — | WO | claimed |
| WO-1997028799-A1 | APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF DRUG ABUSE | RHONE POULENC RORER S.A. (FR) | 1997-08-14 | — | — | WO | claimed |